Goldman Sachs made significant rating changes across its U.S. biopharma coverage on Tuesday, upgrading the likes of Eli Lilly ...

Johnson & Johnson and Pfizer are two of the world's largest pharmaceutical companies with diversified healthcare portfolios. J&J operates through pharmaceuticals and medical devices divisions. In ...

Healthcare companies saw their shares fall further on Monday, deepening losses from last week. The darkening economic backdrop continued to hit drugmakers such as Eli Lilly, Johnson & Johnson and ...

Republican U.S. Senator Ron Johnson Requests COVID-19 Vaccine Records and Communications from Moderna, Pfizer, BioNTech, and Johnson & Johnson ...

Pfizer has vaulted ahead with its respiratory syncytial virus (RSV) vaccine, closing the gap with GlaxoSmithKline and Johnson & Johnson as the companies strive to bring the first licensed shot to ...

Stocks recently featured in the blog include: Johnson & Johnson JNJ and Pfizer PFE. Here are highlights from Thursday’s Analyst Blog: J&J vs. Pfizer: Which Big Pharma Stock Is the Better Buy Today?